tirzepatide for rheumatoid arthritis GLP-1 Medications and Arthritis: What the 2025 Research Actually Shows GLP-1 Medications and Rheumatoid Arthritis:

Tirzepatide is FDA-approved for type 2 diabetes under the brand name Mounjaro

The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Special Considerations for PCOS, Prediabetes, and Obesity While the combination of metformin and tirzepatide was born in the field of Type 2 diabetes care, endocrinologists and obesity medicine specialists are increasingly utilizing this dual approach for conditions that occur prior to, or outside of, a formal diabetes diagnosis

Expanded focus on high-cost chronic treatments: Federal policy discussions increasingly target medications used for long-term conditions such as diabetes and obesity because these drugs can create high long-term costs for both individuals and healthcare systems

Regular check-ins and blood tests play a key role in finding the right dose